Sun Exposure and Cancer Survival in Norway: Changes in the Risk of Death with Season of Diagnosis and Latitude

  • Alina Carmen Porojnicu
  • Arne Dahlback
  • Johan Moan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 624)

Abstract

Epidemiological and experimental studies suggest that derivatives of vitamin D may improve prognosis of a number of cancer types. Sun is our most important source of vitamin D. Seasonal variations and latitudinal gradients of calcidiol (the marker of vitamin D status) have been reported. We wanted to investigate if season and latitude play any role for survival from seven different cancer types in Norway. Seasonal and geographical variations of vitamin D were estimated by calculations and were compared with clinical data. For the survival analyses, 249373 cancer patients were followed for three years after diagnosis and the risk of death was analyzed separately for summer- and winter diagnosis, as well as for two geographical regions with different UV exposures. We found a 15–25 % better survival for patients diagnosed during summer and a slight beneficial effect for residents of the high UV region for some of the cancer forms investigated.

Based on our results we suggest that calcidiol concentration at the time of cancer diagnosis is related to survival and discuss briefly ways to improve the vitamin D levels in the general population.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Armstrong BK, Krickcr A, English DR. Sun exposure and skin cancer. Australas J Dermatol 1997; 38Suppl 1:S1–S6.PubMedGoogle Scholar
  2. 2.
    Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941; 191–195.Google Scholar
  3. 3.
    Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9:227–231.PubMedCrossRefGoogle Scholar
  4. 4.
    Garland FC, Garland CF, Gorham ED et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990; 19:614–622.PubMedCrossRefGoogle Scholar
  5. 5.
    Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10:1307–1311.PubMedGoogle Scholar
  6. 6.
    Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70:2861–2869.PubMedCrossRefGoogle Scholar
  7. 7.
    Lefkowitz ES, Garland CF. Sunlight, vitamin D and ovarian cancer mortality rates in US women. Int J Epidemiol 1994; 23:1133–1136.PubMedCrossRefGoogle Scholar
  8. 8.
    Grant WB. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94:1867–1875.PubMedCrossRefGoogle Scholar
  9. 9.
    Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate and nonmelanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002; 59:257–262.PubMedCrossRefGoogle Scholar
  10. 10.
    Berwick M, Armstrong BK, Ben Porat L et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97:195–199.PubMedCrossRefGoogle Scholar
  11. 11.
    Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26:2687–2699.PubMedGoogle Scholar
  12. 12.
    Grant WB. The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res 2006; 26:2605–2614.PubMedGoogle Scholar
  13. 13.
    Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer 2007; 120:1123–1128.PubMedCrossRefGoogle Scholar
  14. 14.
    Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys 2004; 87:532–538.PubMedCrossRefGoogle Scholar
  15. 15.
    Holick MR Vitamin D: photobiology, metabolism and clinical application. In: Arias IM, Boyer JL, Fausto N et al, eds. The liver: biology and photobiology. New York: Raven Press 1994; 543–62.Google Scholar
  16. 16.
    Panidis D, Balaris C, Farmakiotis D et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005; 51:1691–1697.PubMedCrossRefGoogle Scholar
  17. 17.
    Bischof MG, Heinze G, Vierhapper H. Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66:211–215.PubMedCrossRefGoogle Scholar
  18. 18.
    Hahn S, Haselhorst U, Tan S et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114:577–583.PubMedCrossRefGoogle Scholar
  19. 19.
    Hagenfeldt Y, Carlstrom K, Berlin T et al. Effects of orchidectomy and different modes of high dose estrogen treatment on circulating free and total 1,25-dihydroxyvitamin D in patients with prostatic cancer. J Steroid Biochem Mol Biol 1991; 39:155–159.PubMedCrossRefGoogle Scholar
  20. 20.
    Brustad M, Alsaker E, Engelsen O et al. Vitamin D status of middle-aged women at 65–71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004; 7:327–335.PubMedGoogle Scholar
  21. 21.
    Meyer HE, Falch JA, Sogaard AJ et al. Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway, The Oslo Health Study. Bone 2004; 35:412–417.PubMedCrossRefGoogle Scholar
  22. 22.
    Mowe M, Bohmer T, Haug E. Vitamin D deficiency among hospitalized and home-bound elderly. Tids-skr Nor Laegeforen 1998; 118:3929–3931.Google Scholar
  23. 23.
    Sem SW, Sjoen RJ, Trygg K et al. Vitamin D status of two groups of elderly in Oslo: living in old peoples homes and living in own homes. Compr Gerontol [A] 1987; 1:126–130.Google Scholar
  24. 24.
    Vik T, Try K, Stromme JH. The vitamin D status of man at 70 degrees north. Scand J Clin Lab Invest 1980; 40:227–232.PubMedCrossRefGoogle Scholar
  25. 25.
    Moan J, Porojnicu AC, Robsahm TE et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 2005; 78:189–193.PubMedCrossRefGoogle Scholar
  26. 26.
    Madronich S, McKenzie RL, Bjorn LO et al. Changes in biologically active ultraviolet radiation reaching the Earths surface. J Photochem Photobiol B 1998; 46:5–19.PubMedCrossRefGoogle Scholar
  27. 27.
    Stamnes K, Tsay SC, Wiscombe W et al. Numerically stable algorithm for discrete-ordinate-method for radiative transfer in multiple scattering and emitting layered media. Appl Opt 1988:2502–2509.Google Scholar
  28. 28.
    Dahlback A, Stamnes K. A new spherical model for computing the radiation field available for photolysis and heating rate at twilight. Planet Space Sci 1991:671–683.Google Scholar
  29. 29.
    MacLaughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 1982; 216:1001–1003.PubMedCrossRefGoogle Scholar
  30. 30.
    Moan J, Dahlback A, Henriksen T et al. Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes. Cancer Res 1989; 49:5207–5212.PubMedGoogle Scholar
  31. 31.
    Statistics Norway. http://www.ssb.no/english/subjects/02/01/10/innvbef_en/. 24-11-2005 (Accessed on February 2007).Google Scholar
  32. 32.
    Robsahm TE, Tretli S, Dahlback A et al. Vitamin D3 from sunlight may improve the prognosis of breast-, colon-and prostate cancer (Norway). Cancer Causes Control 2004; 15:149–158.PubMedCrossRefGoogle Scholar
  33. 33.
    Johansson L, Solvoll K. Norkost 1997 Norwegian National Dietary Survey 45. 1999. Oslo, Statens rid for ernæring of fysisk aktivitet. Ref Type: ReportGoogle Scholar
  34. 34.
    Porojnicu AC, Robsahm TE, Dahlback A et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role? Lung Cancer 2005. DOI: 10.1016/Jlungcan 2006:11–013.Google Scholar
  35. 35.
    Porojnicu AC, Lagunova Z, Robsahm TE et al. Changes in risk of death from breast cancer with season and latitude: Sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat 2007; 102:323–328.PubMedCrossRefGoogle Scholar
  36. 36.
    Brot C, Vestergaard P, Kolthoff N et al. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 2001; 86Suppl 1:S97–103.PubMedCrossRefGoogle Scholar
  37. 37.
    Lund B, Sorensen OH. Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 1979; 39:23–30.PubMedCrossRefGoogle Scholar
  38. 38.
    Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16:83–95.PubMedCrossRefGoogle Scholar
  39. 39.
    Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002; 9:45–59.PubMedCrossRefGoogle Scholar
  40. 40.
    Gewirtz DA, Sundaram S, Magnet KJ. Influence of topoisomerase II inhibitors and ionizing radiation on growth arrest and cell death pathways in the breast tumor cell. Cell Biochem Biophys 2000; 33:19–31.PubMedCrossRefGoogle Scholar
  41. 41.
    James SY, Mackay AG, Colston KW. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 1995; 14:391–394.PubMedCrossRefGoogle Scholar
  42. 42.
    Ravid A, Rocker D, Machlenkin A et al. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 1999; 59:862–867.PubMedGoogle Scholar
  43. 43.
    Vink-van Wijngaarden T, Pols HA, Buurman CJ et al. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. Cancer Res 1994; 54:5711–5717.PubMedGoogle Scholar
  44. 44.
    Wang Q, Yang W, Uytingco MS et al. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 2000; 60:2040–2048.PubMedGoogle Scholar
  45. 45.
    Polek TC, Weigel NL. Vitamin D and prostate cancer. J Androl 2002; 23:9–17.PubMedGoogle Scholar
  46. 46.
    Ting HJ, Hsu J, Bao BY et al. Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha, 25-dihydroxyvitamin D(3). Cancer Lett 2007; 247:122–129.PubMedCrossRefGoogle Scholar
  47. 47.
    Bao BY, Yao J, Lee YF. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006; 27:1883–1893.PubMedCrossRefGoogle Scholar
  48. 48.
    Bao BY, Yeh SD, Lee YF. 1alpha, 25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases. Carcinogenesis 2006; 27:32–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Gonzalez-Sancho JM, Larriba MJ, Ordonez-Moran P et al. Effects of lalpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res 2006; 26:2669–2681.PubMedGoogle Scholar
  50. 50.
    Cross HS, Bises G, Lechner D et al. The Vitamin D endocrine system of the gut-its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 2005; 97:121–128.PubMedCrossRefGoogle Scholar
  51. 51.
    Guzey M, Sattler C, DeLuca HE Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation and programmed cell death in two small cell lung carcinoma cell lines. Biochem Biophys Res Commun 1998; 249:735–744.PubMedCrossRefGoogle Scholar
  52. 52.
    Nakagawa K, Kawaura A, Kato S et al. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2004; 89–90:545–547.PubMedCrossRefGoogle Scholar
  53. 53.
    Nakagawa K, Kawaura A, Kato S et al. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005; 26:429–440.PubMedCrossRefGoogle Scholar
  54. 54.
    Nakagawa K, Sasaki Y, Kato S et al. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005; 26:1044–1054.PubMedCrossRefGoogle Scholar
  55. 55.
    DeLuca HF, Schnoes HK. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 1976; 45:631–66. 631–666.PubMedCrossRefGoogle Scholar
  56. 56.
    Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin d(3)-l alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86:888–894.PubMedCrossRefGoogle Scholar
  57. 57.
    Lim HS, Roychoudhuri R, Peto J et al. Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 2006; 119:1530–1536.PubMedCrossRefGoogle Scholar
  58. 58.
    Porojnicu AC, Robsahm TE, Hansen Ree A et al. Season of diagnosis is a prognostic factor in Hodgkin lymphoma. A possible role of sun-induced vitamin D. Br J Cancer 2005; 93:571–574.PubMedCrossRefGoogle Scholar
  59. 59.
    Reichrath J. The challenge resulting from positive and negative effects of sunlight: How much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol 2006; 92:9–16.PubMedCrossRefGoogle Scholar
  60. 60.
    Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79:362–371.PubMedGoogle Scholar
  61. 61.
    Hansen S, Norstein J, Næss, A. Cancer in Norway 2001. Cancer Registry in Norway. Oslo 2004; 36–37.Google Scholar
  62. 62.
    Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004; 89–90:575–579.PubMedCrossRefGoogle Scholar
  63. 63.
    Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006; 136:1117–1122.PubMedGoogle Scholar
  64. 64.
    Calvo MS, Whiting SJ. Public health strategies to overcome barriers to optimal vitamin D status in populations with special needs. J Nutr 2006; 136:1135–1139.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2008

Authors and Affiliations

  • Alina Carmen Porojnicu
    • 1
  • Arne Dahlback
    • 2
  • Johan Moan
    • 1
    • 2
  1. 1.Deparment of Radiation BiologyInstitute for Cancer ResearchMontebello, OsloNorway
  2. 2.Department of PhysicsUniversity of OsloOsloNorway

Personalised recommendations